Lastly, ruxolitinib inhibited the expression of CXC10 and CXCL11 by MDMs from healthy subjects and by macrophages isolated from the synovial fluid of patients with rheumatoid arthritis (Yarilina et al., 2012). This evidence concerns the gene CXCL11 and rheumatoid arthritis.